PRODUCT : GLIZA MF

CATEGORY :
ANTI-DIABETIC
Composition :
Gliclazide 80mg and Metformin 500mg Tablets.
Indication
NIDDM patients not controlled with monotherapy in obese patients
  1. Corrects both defects in such patients.
  2. Increases insulin secretion.
  3. Improves insulin sensitivity.
  4. No Weight gain
Dosage
1 tablet B.D.
Contraindications
HYPERSENSITIVITY; TYPE 1 DIABETES MALLITUS; SEVERE RENAL & hepatic impairment; diabetic coma, diabetic ketoacidosis; cardiac failure.
Precautions
Hypoglycaemia. May require insulins during metabolic stress.
Mechanism Of Action
Gliclazide Increases insulin secretion and Metformin improves insulin sensitivity also reduces glucose production in the liver thus provides dual benefits because of the complimentary action.
DISCLAIMER : This product is available only in India against valid prescription from a Registered Medical Practitioner. This is not an offer for sale.